Bristol-Myers CEO: We're 'one step closer to creating that great company' with Celgene

Celgene brings to Bristol-Myers five late-stage products that could be approved in the near term, Caforio said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.